Search Results - "Serroukh, Yasmina"
-
1
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands
Published in Cancers (30-08-2023)“…The real-world results of chimeric antigen receptor T-cell (CAR-T) therapy for patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)…”
Get full text
Journal Article -
2
The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes
Published in eLife (28-02-2018)“…Cytotoxic CD4 (CD4 ) T cells are emerging as an important component of antiviral and antitumor immunity, but the molecular basis of their development remains…”
Get full text
Journal Article -
3
Alterations of the Erythrocyte Membrane during Sepsis
Published in Critical Care Research and Practice (01-01-2012)“…Erythrocytes have been long considered as “dead” cells with transport of oxygen (O2) as their only function. However, the ability of red blood cells (RBCs) to…”
Get full text
Journal Article -
4
High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients
Published in Journal of antimicrobial chemotherapy (05-07-2023)“…Abstract Objectives Immunocompromised patients have an increased risk of severe or prolonged COVID-19. Currently available drugs are registered to treat…”
Get full text
Journal Article -
5
Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment
Published in Blood reviews (01-01-2023)“…Acute myeloid leukemia (AML) is a cancer that originates from the bone marrow (BM). Under physiological conditions, the bone marrow supports the homeostasis of…”
Get full text
Journal Article -
6
A Propensity Score-Matched Analysis on the Outcomes of Brexucabtagene Autoleucel from Zuma-2 Study and Allogeneic Stem Cell Transplantation from the EBMT Database in Relapsed and Refractory Post-Btki Mantle Cell Lymphoma
Published in Blood (02-11-2023)“…Introduction Brexucabtagene autoleucel (brexu-cel), an autologous anti-CD19 CAR T-cell therapy, is approved in the US for the treatment of relapsed/refractory…”
Get full text
Journal Article -
7
Bispecific T-Cell Engagers for B-Cell NON-Hodgkin Lymphoma Patients before Allogeneic Stem Cell Transplantation. a Study on Behalf Od Geth-TC
Published in Blood (02-11-2023)“…Background: Bispecific T-cell engagers antibodies (BiTEs) have shown promising efficacy across B-cell non-Hodgkin lymphoma (BCL) subtypes. If a response is…”
Get full text
Journal Article -
8
Recognising inequalities in haematopoietic stem-cell transplantation and cellular therapy training
Published in The Lancet. Haematology (01-05-2022)Get full text
Journal Article -
9
Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes
Published in Annals of neurology (01-12-2012)“…Objective: Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disease caused in almost all cases by homozygosity for a GAA trinucleotide…”
Get full text
Journal Article -
10
Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective
Published in Transplantation and cellular therapy (01-03-2022)“…•Both autologous and allogeneic hematopoietic stem cell transplantation (HSCT) have curative potential.•Novel therapies, such as immune checkpoint inhibitors…”
Get full text
Journal Article -
11
Central role and mechanisms of [beta]-cell dysfunction and death in friedreich ataxia-associated diabetes
Published in Annals of neurology (01-12-2012)“…Objective: Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disease caused in almost all cases by homozygosity for a GAA trinucleotide…”
Get full text
Journal Article